Bing

SEARCH HISTORY

Swiss biotech firm AC Immune is one step closer to a potential stock market listing after a decision this week ... Roche has been encouraged by the promise of drugs from Eli Lilly (LLY.N) and Biogen (BIIB.O) that work in a similar way and believes it ...
Reuters · ByBen Hirschler · 7/24/2015
AC Immune
Thank you for reading our articles. Our market commentary is 100% absolutely FREE. Get ready for weekly commentary on over 300 of Wall Streets most undervalued trades. Your next 100% gainer could be only 24 hours away. Join our elite group of …
financialstrend.com · 4/4/2014
Jim Cramer highlighted Eli Lilly (NYSE: LLY) on last night's Mad Money, calling it a stock that will help investors sleep at night given its 5.2% dividend yield. Interestingly, Cramer said he believes that Eli Lilly's stock has just recently bottomed.
StreetInsider · 12/23/2008
Fava beans, s&p, olive oil, chopped scallions, chopped shallot, Arborio rice, dry white wine, vegetable stock (about 7 cups), butter, fresh grated Parmegiana or Grana Padano Cheese. Steam the florets for 1 minute – …
Forex Street · 7/23/2015
Dazu berichtet yahoo.com: Big tech could put a damper on stocks Wednesday, after earnings took an ugly turn late Tuesday and Apple's stock was crushed after the closing bell . Bruised tech could be drag for stocks. weiterlesen ... Weitere Nachricht dazu ...
AD HOC News · 7/22/2015
The stock market ended the midweek session on a lower note with ... HUB.B, IQNT, IVC, JNS, KKR, LAZ, LLY, LUV, MHO, MJN, MMM, NDAQ, NUE, NWE, ORI, PENN, PHM, PJC, POOL, PRLB, PSTB, PTEN, RS, RTN, SFE, SNA, SQNS, STC, SYNT, UAL …
Briefing Live Market Analysis · 7/22/2015
Eli Lilly and Co (NYSE:LLY) is off 2.5% at $84.44, ahead of Monday's highly anticipated (albeit limited) trial results on Alzheimer's treatment solanezumab. The pharmaceutical stock's options pits are busy, too, with intraday volume at nearly four times ...
Schaeffer's Investment Research · 6/12/2015
LLY is up $3.66 at $85.92 on heavy volume. Midway through trading Thursday, 6.07 million shares of Eli Lilly & Co. have exchanged hands as compared to its average daily volume of 5.60 million shares. The stock has ranged in a price between $84.10 – …
Wall Street Pit · 6/25/2015
Your own personalized stock watchlist! It's a 100% FREE Motley Fool service... Click Here Now Pharmaceutical giant Eli Lilly (NYSE: LLY ) has been gaining momentum lately. The excitement surrounding its developmental Alzheimer's drug solanezumab ...
The Motley Fool · ByMax Macaluso · 10/15/2012
NEW YORK (TheStreet) -- BMO Capital Markets raised its price target for Eli Lilly to $92 from $74 on Thursday, reiterating its "market perform" rating for the drug manufacturer. The analyst firm raised its 2015 EPS estimates for Eli Lilly to $3.37 a share ...
Finanzen · 7/16/2015

Eli Lilly and Company

Company
Eli Lilly and Company is an American global pharmaceutical company with headquarters located in Indianapolis, Indiana, in t…
Eli Lilly and Company is an American global pharmaceutical company with headquarters located in Indianapolis, Indiana, in the United States. The company also has offices in Puerto Rico and 17 other countries. Their products are sold in approximately 125 countries. The company was founded in 1876 by Col. Eli Lilly, a pharmaceutical chemist and veteran of the American Civil War, after whom the company was named.
Data from: Wikipedia · Freebase